- Previous Close
511.68 - Open
512.61 - Bid 499.00 x 900
- Ask 500.10 x 1000
- Day's Range
499.49 - 513.36 - 52 Week Range
493.30 - 627.88 - Volume
1,787,671 - Avg. Volume
1,919,601 - Market Cap (intraday)
188.691B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
30.29 - EPS (TTM)
16.51 - Earnings Date Apr 22, 2025 - Apr 28, 2025
- Forward Dividend & Yield 1.72 (0.34%)
- Ex-Dividend Date Mar 14, 2025
- 1y Target Est
659.08
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
www.thermofisher.com125,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TMO
View MorePerformance Overview: TMO
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TMO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TMO
View MoreValuation Measures
Market Cap
188.69B
Enterprise Value
214.40B
Trailing P/E
30.26
Forward P/E
21.46
PEG Ratio (5yr expected)
1.85
Price/Sales (ttm)
4.47
Price/Book (mrq)
3.81
Enterprise Value/Revenue
5.00
Enterprise Value/EBITDA
18.59
Financial Highlights
Profitability and Income Statement
Profit Margin
14.77%
Return on Assets (ttm)
4.90%
Return on Equity (ttm)
13.13%
Revenue (ttm)
42.88B
Net Income Avi to Common (ttm)
6.34B
Diluted EPS (ttm)
16.51
Balance Sheet and Cash Flow
Total Cash (mrq)
5.57B
Total Debt/Equity (mrq)
66.10%
Levered Free Cash Flow (ttm)
6.6B